Paul Tudor Jones's IDXX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 6,614 shares of IDEXX Laboratories, Inc. (IDXX) worth $4.23 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in IDXX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 36,086 shares. Largest reduction occurred in Q2 2025, reducing 20,125 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +6,002 | Add 0.00% | 6,000 | $44.83 |
| Q3 2013 | -6,000 | Sold Out | 0 | $0.00 |
| Q4 2013 | +4,814 | New Buy | 4,814 | $53.18 |
| Q1 2014 | -4,814 | Sold Out | 0 | $0.00 |
| Q2 2014 | +3,200 | New Buy | 3,200 | $66.88 |
| Q3 2014 | +17,882 | Add 558.81% | 21,082 | $58.91 |
| Q4 2014 | -16,682 | Reduce 79.13% | 4,400 | $74.09 |
| Q1 2015 | -4,400 | Sold Out | 0 | $0.00 |
| Q2 2015 | +10,730 | New Buy | 10,730 | $64.12 |
| Q3 2015 | -19 | Reduce 0.18% | 10,711 | $74.22 |
| Q4 2015 | -10,711 | Sold Out | 0 | $0.00 |
| Q2 2016 | +5,712 | New Buy | 5,712 | $92.79 |
| Q3 2016 | -1,113 | Reduce 19.49% | 4,599 | $112.63 |
| Q4 2016 | -4,599 | Sold Out | 0 | $0.00 |
| Q4 2017 | +4,524 | New Buy | 4,524 | $156.28 |
| Q1 2018 | -3,117 | Reduce 68.90% | 1,407 | $191.19 |
| Q2 2018 | +2,405 | Add 170.93% | 3,812 | $218.00 |
| Q3 2018 | -780 | Reduce 20.46% | 3,032 | $249.67 |
| Q4 2018 | -3,032 | Sold Out | 0 | $0.00 |
| Q1 2020 | +4,791 | New Buy | 4,791 | $242.33 |
| Q2 2020 | -1,328 | Reduce 27.72% | 3,463 | $330.06 |
| Q3 2020 | +3,103 | Add 89.60% | 6,566 | $393.09 |
| Q4 2020 | +4,138 | Add 63.02% | 10,704 | $499.91 |
| Q1 2021 | -4,155 | Reduce 38.82% | 6,549 | $489.23 |
| Q2 2021 | -6,549 | Sold Out | 0 | $0.00 |
| Q3 2021 | +5,911 | New Buy | 5,911 | $621.89 |
| Q4 2021 | -5,911 | Sold Out | 0 | $0.00 |
| Q2 2022 | +11,619 | New Buy | 11,619 | $350.72 |
| Q3 2022 | -7,387 | Reduce 63.58% | 4,232 | $325.85 |
| Q4 2022 | +7,750 | Add 183.13% | 11,982 | $0.41 |
| Q1 2023 | -11,982 | Sold Out | 0 | $0.00 |
| Q2 2023 | +13,393 | New Buy | 13,393 | $502.23 |
| Q3 2023 | -10,991 | Reduce 82.07% | 2,402 | $437.27 |
| Q4 2023 | -2,402 | Sold Out | 0 | $0.00 |
| Q2 2024 | +1,280 | New Buy | 1,280 | $487.20 |
| Q3 2024 | -1,280 | Sold Out | 0 | $0.00 |
| Q4 2024 | +1,966 | New Buy | 1,966 | $413.44 |
| Q1 2025 | +36,086 | Add 1835.50% | 38,052 | $419.95 |
| Q2 2025 | -20,125 | Reduce 52.89% | 17,927 | $536.34 |
| Q3 2025 | -11,313 | Reduce 63.11% | 6,614 | $638.89 |
Paul Tudor Jones's IDEXX Laboratories Investment FAQs
Paul Tudor Jones first purchased IDEXX Laboratories, Inc. (IDXX) in Q2 2013, acquiring 6,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held IDEXX Laboratories, Inc. (IDXX) for 40 quarters since Q2 2013.
Paul Tudor Jones's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q1 2025, adding 38,052 shares worth $15.98 M.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 6,614 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $4.23 M.
As of the Q3 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in IDEXX Laboratories, Inc. (IDXX) was 38,052 shares, as reported at the end of Q1 2025.